{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:24:52Z","timestamp":1792797892766,"version":"4.5.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pathologic fractures, especially of the axial skeleton, are extremely common in patients with multiple myeloma and cluster around the time of diagnosis. Osteoporotic fractures seem to be less of a problem in these patients.<\/jats:p>\n                  <jats:p>Introduction: It is generally believed that fractures are common in patients with multiple myeloma as a result of lytic bone lesions, generalized bone loss, and\/or elevated bone turnover from excessive cytokine production, but the actual risk of pathologic versus osteoporotic fractures has not been quantified.<\/jats:p>\n                  <jats:p>Materials and Methods: In a population-based retrospective cohort study, 165 Olmsted County, MN, residents with myeloma diagnosed from 1945 to 2001 (55% men; mean age, 70.7 \u00b1 11.1 years) were followed for 537 person-years. The relative risk of fractures was assessed by standardized incidence ratios (SIRs), and risk factors were evaluated in proportional hazards models.<\/jats:p>\n                  <jats:p>Results: Altogether, 134 patients experienced 463 fractures. In the year before diagnosis, 16 times more fractures were observed than expected, mostly pathologic fractures of the vertebrae and ribs. Subsequently, there was a 9-fold increase in fracture risk. However, 69% of these fractures were pathologic, and another 11% were found incidentally on myeloma monitoring. With the latter two groups excluded, subsequent fracture risk was elevated 3-fold, with a 2-fold increase in the risk of an osteoporotic fracture. In multivariate analyses, the predictors of overall fracture risk were oral corticosteroid use and elevated serum calcium levels, whereas pathologic fractures were additionally predicted by use of chemotherapy.<\/jats:p>\n                  <jats:p>Conclusion: There is a dramatic increase in fractures around the time of diagnosis of myeloma, most of which are pathologic fractures. The most important predictor of overall fracture risk is oral corticosteroid use.<\/jats:p>","DOI":"10.1359\/jbmr.041131","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T04:26:11Z","timestamp":1146111971000},"page":"487-493","source":"Crossref","is-referenced-by-count":288,"title":["Fracture Risk With Multiple Myeloma: A Population-Based Study"],"prefix":"10.1093","volume":"20","author":[{"suffix":"III","given":"L Joseph","family":"Melton","sequence":"first","affiliation":[{"name":"Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Kyle","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara J","family":"Achenbach","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann L","family":"Oberg","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Vincent","family":"Rajkumar","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,4]]},"reference":[{"key":"2024013019230531300_bib1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0037-1963(01)90020-4","article-title":"Myeloma bone disease","volume":"38","author":"Callander","year":"2001","journal-title":"Sem Hematol"},{"key":"2024013019230531300_bib2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9343(92)90190-M","article-title":"Bone densitometry in patients with multiple myeloma","volume":"93","author":"Mariette","year":"1992","journal-title":"Am J Med"},{"key":"2024013019230531300_bib3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1600-0609.1994.tb01327.x","article-title":"Dual energy X-ray absorptiometry measurements of bone mineral density in myeloma","volume":"53","author":"Holmes","year":"1994","journal-title":"Eur J Haematol"},{"key":"2024013019230531300_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/8756-3282(94)90890-7","article-title":"Biologic, histologic and densitometric effects of oral risedronate on bone in patients with multiple myeloma","volume":"15","author":"Roux","year":"1994","journal-title":"Bone"},{"key":"2024013019230531300_bib5","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/1097-0142(19951101)76:9<1559::AID-CNCR2820760910>3.0.CO;2-R","article-title":"Evolution of bone densitometry in patients with myeloma treated with conventional or intensive therapy","volume":"76","author":"Mariette","year":"1995","journal-title":"Cancer"},{"key":"2024013019230531300_bib6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1365-2141.1997.1042920.x","article-title":"Biochemical, histomorphometric and densitometric changes in patients with multiple myeloma: Effects of glucocorticoid therapy and disease activity","volume":"97","author":"Diamond","year":"1997","journal-title":"Br J Haematol"},{"key":"2024013019230531300_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/10428199809059252","article-title":"Biologic and therapeutic determinants of bone mineral density in multiple myeloma","volume":"32","author":"Dhodapkar","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"2024013019230531300_bib8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1046\/j.1445-5994.2001.00055.x","article-title":"Non-invasive markers of bone turnover and plasma cytokines differ in osteoporotic patients with multiple myeloma and monoclonal gammopathies of undetermined significance","volume":"31","author":"Diamond","year":"2001","journal-title":"Intern Med J"},{"key":"2024013019230531300_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.0954-6820.1982.tb01895.x","article-title":"Bone mineral content in myelomatosis","volume":"211","author":"Ingeberg","year":"1982","journal-title":"Acta Med Scand"},{"key":"2024013019230531300_bib10","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1600-0609.1996.tb01395.x","article-title":"Assessment of bone involvement in patients with multiple myeloma using bone densitometry","volume":"57","author":"Abildgaard","year":"1996","journal-title":"Eur J Haematol"},{"key":"2024013019230531300_bib11","first-page":"108","article-title":"Dual-energy x-ray absorptiometry in patients with multiple myeloma and benign gammopathies","volume":"14","author":"Laroche","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"2024013019230531300_bib12","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1200\/JCO.2000.18.7.1570","article-title":"Osteoporosis due to cancer treatment: Pathogenesis and management","volume":"18","author":"Pfeilschifter","year":"2000","journal-title":"J Clin Oncol"},{"key":"2024013019230531300_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"2024013019230531300_bib14","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"key":"2024013019230531300_bib15","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0140-6736(92)93075-X","article-title":"Randomised, placebo-controlled multicenter trial of clodronate in multiple myeloma","volume":"340","author":"Lahtinen","year":"1992","journal-title":"Lancet"},{"key":"2024013019230531300_bib16","volume-title":"Cancer Facts and Figures\u00a02003","author":"American Cancer Society","year":"2003"},{"key":"2024013019230531300_bib17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4065\/71.3.266","article-title":"History of the Rochester Epidemiology Project","volume":"71","author":"Melton","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"2024013019230531300_bib18","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1002\/cncr.20652","article-title":"Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over six decades","volume":"101","author":"Kyle","year":"2004","journal-title":"Cancer"},{"key":"2024013019230531300_bib19","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1056\/NEJM199711133372012","article-title":"The threat to medical-records research","volume":"337","author":"Melton","year":"1997","journal-title":"N Engl J Med"},{"key":"2024013019230531300_bib20","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma: Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"2024013019230531300_bib21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jbmr.5650070214","article-title":"Incidence of clinically diagnosed vertebral fractures: A population-based study in Rochester, Minnesota, 1985\u20131989","volume":"7","author":"Cooper","year":"1992","journal-title":"J Bone Miner Res"},{"key":"2024013019230531300_bib22","first-page":"701","article-title":"Limb fractures in a defined population. I. Frequency and distribution","volume":"54","author":"Garraway","year":"1979","journal-title":"Mayo Clin Proc"},{"key":"2024013019230531300_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00003086-198103000-00008","article-title":"Epidemiologic features of pelvic fractures","volume":"155","author":"Melton","year":"1981","journal-title":"Clin Orthop"},{"key":"2024013019230531300_bib24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00003086-198208000-00003","article-title":"Epidemiologic features of humeral fractures","volume":"168","author":"Rose","year":"1982","journal-title":"Clin Orthop"},{"key":"2024013019230531300_bib25","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00003086-198809000-00033","article-title":"Epidemiology of diaphyseal and distal femoral fractures in Rochester, Minnesota, 1965\u20131984","volume":"234","author":"Arneson","year":"1988","journal-title":"Clin Orthop"},{"key":"2024013019230531300_bib26","first-page":"146","article-title":"Downturn in hip fracture incidence","volume":"111","author":"Melton","year":"1996","journal-title":"Public Health Rep"},{"key":"2024013019230531300_bib27","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s001980050073","article-title":"Long-term trends in the incidence of distal forearm fractures","volume":"8","author":"Melton","year":"1998","journal-title":"Osteoporos Int"},{"key":"2024013019230531300_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s001980050113","article-title":"Fracture incidence in Olmsted County, Minnesota: Comparison of urban with rural rates and changes in urban rates over time","volume":"9","author":"Melton","year":"1999","journal-title":"Osteoporos Int"},{"key":"2024013019230531300_bib29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/biomet\/40.3-4.354","article-title":"Some simple approximate tests for Poisson variates","volume":"40","author":"Cox","year":"1953","journal-title":"Biometrika"},{"key":"2024013019230531300_bib30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non-parametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"2024013019230531300_bib31","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: New representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"key":"2024013019230531300_bib32","volume-title":"The Statistical Analysis of Failure Time Data","author":"Kalbfleisch","year":"1980"},{"key":"2024013019230531300_bib33","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling Survival Data: Extending the Cox Model","author":"Therneau","year":"2000"},{"key":"2024013019230531300_bib34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1359\/jbmr.0301212","article-title":"Fracture risk in monoclonal gammopathy of undetermined significance","volume":"19","author":"Melton","year":"2004","journal-title":"J Bone Miner Res"},{"key":"2024013019230531300_bib35","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"key":"2024013019230531300_bib36","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1200\/JCO.2002.06.037","article-title":"American Society of Clinical Oncology Clinical Practice Guidelines: The role of bisphosphonates in multiple myeloma","volume":"20","author":"Berenson","year":"2002","journal-title":"J Clin Oncol"},{"key":"2024013019230531300_bib37","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0889-857X(05)70194-0","article-title":"Treatment of osteoporosis with bisphosphonates","volume":"27","author":"Watts","year":"2001","journal-title":"Rheum Dis Clin North Am"},{"key":"2024013019230531300_bib38","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroid-induced osteoporosis: A meta-analysis","volume":"13","author":"van Staa","year":"2002","journal-title":"Osteoporos Int"},{"key":"2024013019230531300_bib39","first-page":"251","volume-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"Clines","year":"2003","edition":"5th ed."},{"key":"2024013019230531300_bib40","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1359\/jbmr.1998.13.5.763","article-title":"A unitary model for involutional osteoporosis: Estrogen deficiency causes both Type I and Type II osteoporosis in postmenopausal women and contributes to bone loss in aging men","volume":"13","author":"Riggs","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2024013019230531300_bib41","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","article-title":"Patients with prior fractures have an increased risk of future fractures: A summary of the literature and statistical synthesis","volume":"15","author":"Klotzbuecher","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2024013019230531300_bib42","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0889-8529(02)00062-2","article-title":"Secondary osteoporosis","volume":"32","author":"Stein","year":"2003","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2024013019230531300_bib43","doi-asserted-by":"crossref","first-page":"750","DOI":"10.7326\/0003-4819-130-9-199905040-00016","article-title":"The effect of thyroid hormone on skeletal integrity","volume":"130","author":"Greenspan","year":"1999","journal-title":"Ann Intern Med"},{"key":"2024013019230531300_bib44","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archinte.164.2.146","article-title":"Use of statins and fracture: Results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials","volume":"164","author":"Bauer","year":"2004","journal-title":"Arch Intern Med"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2FJBMR.041131","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/20\/3\/487\/56477409\/5650200314.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/20\/3\/487\/56477409\/5650200314.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T11:07:56Z","timestamp":1710328076000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/20\/3\/487-493\/7593069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,1]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,12,4]]},"published-print":{"date-parts":[[2005,3,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.041131","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2005,3,1]]},"published":{"date-parts":[[2005,3,1]]}}}